Tech Company Financing Transactions
Redesign Health Funding Round
Redesign Health secured a $65 million Series C investment round on 9/13/2022. Investors included General Catalyst Partners, CVS Health Ventures and Samsung NEXT.
Transaction Overview
Company Name
Announced On
9/13/2022
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series C
Investors
General Catalyst Partners (Lead Investor) (Hemant Taneja)
Proceeds Purpose
The latest funding will benefit Redesign's own operations and platform, rather than being doled out to the operating companies it has founded.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
85 5th Ave 8th Fl
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Undisclosed
Website
Email Address
Overview
Redesign Health is a company that powers innovation in healthcare by developing technologies, tools, and insights that lower the barriers to change across the industry. Since 2018, exceptional founders have built over two dozen companies at Redesign Health, impacting more than ten million lives across many aspects of the healthcare ecosystem including cancer care, teleaudiology, COVID-19 testing, metabolic health and more.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brett Shaheen
Browse more venture capital transactions:
Prev: 9/13/2022: Patch venture capital transaction
Next: 9/13/2022: Litmus Automation venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs